Cash flow Sionna Therapeutics, Inc.

Equities

SION

US8294011080

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2026-04-15 pm EDT			5-day change	1st Jan Change
45.09 ^USD	+4.13%		+22.03%	+9.60%

Mar. 02	Sionna Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
Mar. 02	Sionna Therapeutics Inc maintains strong cash position with about $310.3 million in cash and cash equivalents, expected to fund operations into 2028	RE

a.QOL_zfwGcz7abjyHVht_4HXtEUsCPDsUsh5qWmMVk2k.FtGP-85hJH-JAm6zZWsR1BuOJilTa2Fw4kRaA05Q-g0akJP5mGMnc5QvfQ

Published financial data: SIONNA THERAPEUTICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2022	2023	2024	2025
Selling General & Admin Expenses, Total	6.77M	9.71M	13.27M	28.72M
R&D Expenses	34.6M	40.63M	57.29M	60.26M
Other Operating Expenses, Total	41.37M	50.33M	70.56M	88.98M
Operating Income	-41.37M	-50.33M	-70.56M	-88.98M
Interest And Investment Income	1.13M	2.77M	8.17M	13.3M
Net Interest Expenses	1.13M	2.77M	8.17M	13.3M
Other Non Operating Income (Expenses)	-	301K	698K	419K
EBT, Excl. Unusual Items	-40.24M	-47.26M	-61.69M	-75.27M
EBT, Incl. Unusual Items	-40.24M	-47.26M	-61.69M	-75.27M
Earnings From Continuing Operations	-40.24M	-47.26M	-61.69M	-75.27M
Net Income to Company	-40.24M	-47.26M	-61.69M	-75.27M
Net Income - (IS)	-40.24M	-47.26M	-61.69M	-75.27M
Net Income to Common Incl Extra Items	-40.24M	-47.26M	-61.69M	-75.27M
Net Income to Common Excl. Extra Items	-40.24M	-47.26M	-61.69M	-75.27M
Per Share Items
Net EPS - Basic	-15.61	-16.11	-15.99	-1.88
Basic EPS - Continuing Operations	-15.61	-16.11	-15.99	-1.88
Basic Weighted Average Shares Outstanding	2.58M	2.93M	3.86M	39.96M
Net EPS - Diluted	-15.61	-16.11	-15.99	-1.88
Diluted EPS - Continuing Operations	-15.61	-16.11	-15.99	-1.88
Diluted Weighted Average Shares Outstanding	2.58M	2.93M	3.86M	39.96M
Normalized Basic EPS	-9.76	-10.07	-9.99	-1.18
Normalized Diluted EPS	-9.76	-10.07	-9.99	-1.18
Supplemental Items
EBITDA	-41.25M	-49.75M	-69.89M	-88.34M
EBITA	-41.37M	-50.33M	-70.56M	-88.98M
EBIT	-41.37M	-50.33M	-70.56M	-88.98M
EBITDAR	-	-	-	-88.75M
Normalized Net Income	-25.15M	-29.54M	-38.56M	-47.04M
Supplemental Operating Expense Items
General and Administrative Expenses	6.77M	9.71M	13.27M	28.72M
Research And Development Expense From Footnotes	34.6M	40.63M	57.29M	60.26M
Net Rental Expense, Total	-	-	-	-419K
Stock-Based Comp., R&D Exp. (Total)	859K	1.14M	1.5M	4.12M
Stock-Based Comp., G&A Exp. (Total)	827K	1.12M	2.21M	7.95M
Total Stock-Based Compensation	1.69M	2.26M	3.71M	12.07M

Fiscal Period: December	2022	2023	2024	2025
Assets
Cash And Equivalents	54.84M	38.52M	37.79M	58.45M
Short Term Investments	27.77M	-	110M	177M
Total Cash And Short Term Investments	82.61M	38.52M	148M	236M
Prepaid Expenses	1.22M	686K	3.46M	5.54M
Total Current Assets	83.83M	39.21M	151M	241M
Gross Property Plant And Equipment	2.14M	12.53M	11.87M	11.27M
Accumulated Depreciation	-344K	-914K	-1.57M	-2.12M
Net Property Plant And Equipment	1.79M	11.62M	10.3M	9.15M
Long-term Investments	-	-	20.5M	74.42M
Other Long-Term Assets, Total	1.74M	1.12M	3.96M	963K
Total Assets	87.37M	51.94M	186M	326M
Liabilities
Accounts Payable, Total	557K	719K	1.19M	769K
Accrued Expenses, Total	7.7M	6.59M	7.67M	9.67M
Current Portion of Leases	-	728K	1.07M	1.27M
Other Current Liabilities	-	-	492K	6K
Total Current Liabilities	8.25M	8.04M	10.42M	11.71M
Long-Term Leases	-	9.75M	8.68M	7.41M
Total Liabilities	8.25M	17.79M	19.1M	19.12M
Preferred Stock Convertible	149M	149M	330M	-
Total Preferred Equity	149M	149M	330M	-
Common Stock, Total	2K	2K	5K	45K
Additional Paid In Capital	2.22M	4.52M	17M	563M
Retained Earnings	-72.14M	-119M	-181M	-256M
Comprehensive Income and Other	-16K	-	368K	540K
Total Common Equity	-69.92M	-115M	-164M	307M
Total Equity	79.12M	34.16M	167M	307M
Total Liabilities And Equity	87.37M	51.94M	186M	326M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.58M	3.05M	44.12M	45M
ECS Total Common Shares Outstanding	2.58M	3.05M	4.72M	44.72M
Book Value / Share	-27.13	-37.66	-34.66	6.86
Tangible Book Value	-69.92M	-115M	-164M	307M
Tangible Book Value Per Share	-27.13	-37.66	-34.66	6.86
Total Debt	0	10.48M	9.75M	8.68M
Net Debt	-82.61M	-28.04M	-158M	-302M
Debt Equivalent Oper. Leases	-	-	-	-3.35M
Account Code - Inventory Valuation	-	3	3	3
Machinery, Total	617K	2.05M	2.18M	2.43M
Full Time Employees	-	28	41	59

Fiscal Period: December	2022	2023	2024	2025
Net Income	-40.24M	-47.26M	-61.69M	-75.27M
Depreciation & Amortization - CF	122K	583K	668K	647K
Depreciation & Amortization, Total	122K	583K	668K	647K
(Gain) Loss on Sale of Investments - (CF)	-400K	-679K	-3M	-3.05M
Stock-Based Compensation (CF)	1.69M	2.26M	3.71M	12.07M
Other Operating Activities, Total	-	2.18M	10.6M	1.96M
Change In Accounts Payable	-1.51M	162K	467K	-417K
Change in Other Net Operating Assets	4.28M	-945K	-3.54M	-2.24M
Cash from Operations	-36.07M	-43.7M	-52.79M	-66.3M
Capital Expenditure	-1.87M	-1.12M	-27K	-377K
Investment in Marketable and Equity Securities, Total	-27.39M	28.47M	-127M	-118M
Cash from Investing	-29.26M	27.35M	-127M	-119M
Issuance of Common Stock	64K	31K	141K	206M
Issuance of Preferred Stock	111M	-	181M	-
Other Financing Activities, Total	-200K	-	-2.5M	-
Cash from Financing	111M	31K	179M	206M
Net Change in Cash	45.52M	-16.32M	-733K	20.66M
Supplemental Items
Levered Free Cash Flow	-	-30.14M	-40.48M	-44.26M
Unlevered Free Cash Flow	-	-30.14M	-40.48M	-44.26M
Change In Net Working Capital	-	407K	730K	987K

Fiscal Period: December	2022	2023	2024	2025
Profitability
Return on Assets	-	-45.16	-37.1	-21.74
Return on Total Capital	-	-50.84	-39.9	-22.61
Return On Equity %	-	-83.45	-61.44	-31.79
Return on Common Equity	-	51.15	44.29	-105.18
Short Term Liquidity
Current Ratio	10.16	4.88	14.49	20.61
Quick Ratio	10.01	4.79	14.16	20.14
Operating Cash Flow to Current Liabilities	-4.37	-5.44	-5.07	-5.66
Long Term Solvency
Total Debt/Equity	-	30.67	5.85	2.83
Total Debt / Total Capital	-	23.47	5.53	2.75
LT Debt/Equity	-	28.54	5.21	2.41
Long-Term Debt / Total Capital	-	21.84	4.92	2.35
Total Liabilities / Total Assets	9.45	34.24	10.28	5.87
Total Debt / EBITDA	-	-0.21	-0.14	-0.1
Net Debt / EBITDA	2	0.56	2.32	3.41
Total Debt / (EBITDA - Capex)	-	-0.21	-0.14	-0.1
Net Debt / (EBITDA - Capex)	1.92	0.55	2.31	3.4
Growth Over Prior Year
EBITDA, 1 Yr. Growth %	-	20.61	40.48	26.4
EBITA, 1 Yr. Growth %	-	21.66	40.18	26.12
EBIT, 1 Yr. Growth %	-	21.66	40.18	26.12
Earnings From Cont. Operations, 1 Yr. Growth %	-	17.45	30.52	22.01
Net Income, 1 Yr. Growth %	-	17.45	30.52	22.01
Normalized Net Income, 1 Yr. Growth %	-	17.45	30.52	22.01
Diluted EPS Before Extra, 1 Yr. Growth %	-	3.21	-0.79	-88.22
Net Property, Plant and Equip., 1 Yr. Growth %	-	547.49	-11.35	-11.14
Total Assets, 1 Yr. Growth %	-	-40.55	257.59	75.48
Tangible Book Value, 1 Yr. Growth %	-	64.29	42.51	-287.42
Common Equity, 1 Yr. Growth %	-	64.29	42.51	-287.42
Cash From Operations, 1 Yr. Growth %	-	21.16	20.8	25.59
Capital Expenditures, 1 Yr. Growth %	-	-40.45	-97.58	1.3K
Levered Free Cash Flow, 1 Yr. Growth %	-	-	34.31	9.35
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	34.31	9.35
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	-	-	30.16	33.25
EBITA, 2 Yr. CAGR %	-	-	30.59	32.96
EBIT, 2 Yr. CAGR %	-	-	30.59	32.96
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	23.81	26.2
Net Income, 2 Yr. CAGR %	-	-	23.81	26.2
Normalized Net Income, 2 Yr. CAGR %	-	-	23.81	26.2
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	1.19	-65.81
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	139.59	-11.24
Total Assets, 2 Yr. CAGR %	-	-	45.81	150.5
Tangible Book Value, 2 Yr. CAGR %	-	-	53.01	63.43
Common Equity, 2 Yr. CAGR %	-	-	53.01	63.43
Cash From Operations, 2 Yr. CAGR %	-	-	20.98	23.17
Capital Expenditures, 2 Yr. CAGR %	-	-	-88	-41.88
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	21.19
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	21.19
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	-	-	-	28.9
EBITA, 3 Yr. CAGR %	-	-	-	29.08
EBIT, 3 Yr. CAGR %	-	-	-	29.08
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	23.21
Net Income, 3 Yr. CAGR %	-	-	-	23.21
Normalized Net Income, 3 Yr. CAGR %	-	-	-	23.21
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-50.59
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	72.14
Total Assets, 3 Yr. CAGR %	-	-	-	55.1
Tangible Book Value, 3 Yr. CAGR %	-	-	-	63.72
Common Equity, 3 Yr. CAGR %	-	-	-	63.72
Cash From Operations, 3 Yr. CAGR %	-	-	-	22.5
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-41.41